Found: 10
Select item for more details and to access through your institution.
EMT and primary ciliogenesis: For better or worse in sickness and in health.
- Published in:
- Genesis: The Journal of Genetics & Development, 2024, v. 62, n. 1, p. 1, doi. 10.1002/dvg.23568
- By:
- Publication type:
- Article
bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses.
- Published in:
- Database: The Journal of Biological Databases & Curation, 2021, v. 2021, p. 1, doi. 10.1093/database/baab007
- By:
- Publication type:
- Article
RE: Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).
- Published in:
- 2020
- By:
- Publication type:
- letter
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 5, p. 825, doi. 10.1007/s12282-024-01597-z
- By:
- Publication type:
- Article
Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 7, p. N.PAG, doi. 10.3390/biom12070901
- By:
- Publication type:
- Article
Targeting of BCL-2 Family Members during Anticancer Treatment: A Necessary Compromise between Individual Cell and Ecosystemic Responses?
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 8, p. 1109, doi. 10.3390/biom10081109
- By:
- Publication type:
- Article
E2F1 interacts with BCL‐xL and regulates its subcellular localization dynamics to trigger cell death.
- Published in:
- EMBO Reports, 2018, v. 19, n. 2, p. 234, doi. 10.15252/embr.201744046
- By:
- Publication type:
- Article
STING-dependent paracriny shapes apoptotic priming of breast tumors in response to anti-mitotic treatment.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-13689-y
- By:
- Publication type:
- Article
Mitochondria at Center of Exchanges between Cancer Cells and Cancer-Associated Fibroblasts during Tumor Progression.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 3017, doi. 10.3390/cancers12103017
- By:
- Publication type:
- Article
Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-64696-z
- By:
- Publication type:
- Article